XML 60 R42.htm IDEA: XBRL DOCUMENT v3.3.1.900
Unaudited Quarterly Results (Tables)
 12 Months Ended
Dec. 31, 2015
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Quarterly Financial Information
Summarized quarterly financial data for the years ended December 31, 2015 and 2014 are set forth in the following tables.
 
 
First Quarter Ended
March 31, 2015
 
Second Quarter Ended
June 30, 2015
 
Third Quarter Ended
September 30, 2015
 
Fourth Quarter Ended
December 31, 2015
 
 
(Unaudited)
Revenues
 
$
869,612

 
$
998,617

 
$
1,137,422

 
$
1,098,077

Net income
 
$
76,021

 
$
194,643

 
$
210,398

 
$
154,994

Net income per share - basic
 
$
0.74

 
$
1.89

 
$
2.04

 
$
1.49

Net income per share - diluted
 
$
0.66

 
$
1.69

 
$
1.82

 
$
1.34

 
 
 
 
 
 
 
 
 
 
 
First Quarter Ended
March 31, 2014*
 
Second Quarter Ended
June 30, 2014*
 
Third Quarter Ended
September 30, 2014*
 
Fourth Quarter Ended
December 31, 2014*
 
 
(Unaudited)
Revenues
 
$
625,740

 
$
665,700

 
$
725,788

 
$
802,329

Net income (1)
 
$
68,305

 
$
96,351

 
$
83,375

 
$
90,095

Net income per share - basic
 
$
0.69

 
$
0.96

 
$
0.83

 
$
0.89

Net income per share - diluted
 
$
0.61

 
$
0.85

 
$
0.73

 
$
0.78

* Certain revisions have been made to the amounts originally reported for quarterly periods ended March 31, June 30, September 30, and December 31, 2014. See Note 14.
(1) Net income in the third quarter of 2014 included a $40.6 million incremental charge related to the Branded Prescription Drug Fee based on final regulations issued by the IRS in July 2014 as described in Note 2 above.